GelbChem, LLC, Seattle, WA 98195, USA; Department of Chemistry, University of Washington, Seattle, WA 98195, USA.
ARCHIMED Life Science GmbH, Leberstraße 20, 1110 Vienna, Austria.
Mol Genet Metab. 2024 Aug;142(4):108517. doi: 10.1016/j.ymgme.2024.108517. Epub 2024 Jun 19.
GM2 gangliosidosis is a group of rare lysosomal storage disorders (LSDs) including Tay-Sachs disease (TSD) and Sandhoff disease (SD), caused by deficiency in activity of either β-hexosaminidase A (HexA) or both β-hexosaminidase A and β-hexosaminidase B (HexB). Methods for screening and diagnosis of TSD and SD include measurement and comparison of the activity of these two enzymes. Here we report a novel method for duplex screening of dried blood spots (DBS) for TSD and SD by liquid chromatography-tandem mass spectrometry (LC-MS/MS). The method requires incubation of a single 3 mm DBS punch with the assay cocktail followed by the injection into the LC-MS/MS. The performance of the method was evaluated by comparing the confirmed TSD and SD patient DBS to random healthy newborn DBS which showed easy discrimination between the three cohorts. The method is multiplexable with other LSD MS/MS enzyme assays which is critical to the continued expansion of the NBS panels.
GM2 神经节苷脂贮积症是一组罕见的溶酶体贮积症(LSD),包括泰萨二氏病(TSD)和桑德霍夫病(SD),由β-己糖胺酶 A(HexA)或β-己糖胺酶 A 和 β-己糖胺酶 B(HexB)活性缺乏引起。TSD 和 SD 的筛查和诊断方法包括测量和比较这两种酶的活性。我们在此报告了一种通过液相色谱-串联质谱法(LC-MS/MS)对干血斑(DBS)进行 TSD 和 SD 双筛的新方法。该方法需要将单个 3mm 的 DBS 打孔与测定混合物孵育,然后注入 LC-MS/MS。通过将确认的 TSD 和 SD 患者的 DBS 与随机健康新生儿的 DBS 进行比较,评估了该方法的性能,结果表明很容易区分这三组。该方法可与其他 LSD MS/MS 酶测定方法多重检测,这对于不断扩展新生儿筛查(NBS)面板至关重要。